Marc Recht

Partner

+1 617 937 2316
mrecht@cooley.com

For over 20 years, Marc Recht has represented life sciences and other healthcare companies and investors in public and private transactions, including securities offerings, joint ventures and M&A matters. He also has extensive experience advising public companies boards of directors and management teams regarding Securities and Exchange Commission periodic disclosure, Sarbanes-Oxley compliance, corporate governance and Nasdaq and New York Stock Exchange rules.

Download full bio

Experience

  • Oncorus – $98 Million IPO 

  • RenalytixAI – $74 Million IPO 

  • Repare Therapeutics - $253 Million IPO 

  • Calliditas Therapeutics - $90 Million IPO 

  • Imara - $75 Million IPO 

  • View all

Excellent in all categories. Marc Recht is 'very technically skilled in corporate matters and plays a strong quarterback role.' – The Legal 500 (2013)
Education

  • Boston College Law School
    JD, magna cum laude, 1999

  • Brandeis University
    BA, with honors, 1995


Admissions & Credentials

Massachusetts

Rankings & Accolades

    Chambers USA: Corporate/M&A: Capital Markets - Massachusetts (2014-2020)

    The Legal 500 US: Healthcare: Life Sciences (2013, 2016, 2020)

    Who's Who Legal: Life Sciences (2017, 2018)

    Super Lawyers: Rising Star (2007, 2010-2013)

    Boston Business Journal: Biotech IPO (2015)


Contact

+1 617 937 2316 office
+1 617 937 2400 fax
mrecht@cooley.com

500 Boylston Street
14th Floor
Boston, MA 02116-3736